USA – Moderna chairman says COVID-19 vaccine could begin phase 2 trials in spring

Phase 1 trial was initiated in record time, after vaccine candidate fast-tracked by US government

Moderna’s chairman Noubar Afeyan has said that phase 2 human trials of the company’s coronavirus vaccine could begin in spring, as pressure mounts for the successful development of a shot against the novel virus.

In March, Moderna launched a phase 1 human trial of its mRNA-based vaccine, named mRNA-1273, with the first patients having already been dosed. The study is being conducted by the US National Institutes of Health (NIH) at Kaiser Permanente Washington Health Research Institute in Seattle.

“It’s difficult to put a specific date on things just because it’s a very dynamic situation,” said Afeyan, according to CNBC…